BIVRX vs. UPRO
Compare and contrast key facts about Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. UPRO is a passively managed fund by ProShares that tracks the performance of the S&P 500 Index (300%). It was launched on Jun 23, 2009.
Performance
BIVRX vs. UPRO - Performance Comparison
Loading graphics...
BIVRX vs. UPRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 3.63% | 4.39% | -9.03% | 16.47% | 49.61% | 44.06% | 11.12% | 11.36% | 3.41% | 8.73% |
UPRO ProShares UltraPro S&P 500 | -14.14% | 31.88% | 63.57% | 68.53% | -56.84% | 98.64% | 10.09% | 102.30% | -25.11% | 32.43% |
Returns By Period
In the year-to-date period, BIVRX achieves a 3.63% return, which is significantly higher than UPRO's -14.14% return.
BIVRX
- 1D
- -2.18%
- 1M
- 1.93%
- YTD
- 3.63%
- 6M
- 8.69%
- 1Y
- 4.72%
- 3Y*
- 0.96%
- 5Y*
- 13.24%
- 10Y*
- —
UPRO
- 1D
- 2.26%
- 1M
- -13.81%
- YTD
- -14.14%
- 6M
- -11.56%
- 1Y
- 34.19%
- 3Y*
- 38.31%
- 5Y*
- 17.16%
- 10Y*
- 25.53%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. UPRO - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than UPRO's 0.92% expense ratio.
Return for Risk
BIVRX vs. UPRO — Risk / Return Rank
BIVRX
UPRO
BIVRX vs. UPRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIVRX | UPRO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.22 | 0.63 | -0.41 |
Sortino ratioReturn per unit of downside risk | 0.50 | 1.21 | -0.71 |
Omega ratioGain probability vs. loss probability | 1.05 | 1.18 | -0.13 |
Calmar ratioReturn relative to maximum drawdown | 0.30 | 1.06 | -0.76 |
Martin ratioReturn relative to average drawdown | 0.69 | 4.22 | -3.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIVRX | UPRO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.22 | 0.63 | -0.41 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.78 | 0.34 | +0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.48 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.89 | 0.60 | +0.29 |
Correlation
The correlation between BIVRX and UPRO is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BIVRX vs. UPRO - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 1.86%, more than UPRO's 1.02% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 1.86% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% | 0.00% | 0.00% |
UPRO ProShares UltraPro S&P 500 | 1.02% | 0.84% | 0.93% | 0.74% | 0.52% | 0.06% | 0.11% | 0.41% | 0.63% | 0.00% | 0.12% | 0.34% |
Drawdowns
BIVRX vs. UPRO - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -18.29%, smaller than the maximum UPRO drawdown of -76.82%. Use the drawdown chart below to compare losses from any high point for BIVRX and UPRO.
Loading graphics...
Drawdown Indicators
| BIVRX | UPRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.29% | -76.82% | +58.53% |
Max Drawdown (1Y)Largest decline over 1 year | -13.79% | -33.38% | +19.59% |
Max Drawdown (5Y)Largest decline over 5 years | -17.66% | -63.94% | +46.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.82% | — |
Current DrawdownCurrent decline from peak | -3.34% | -18.68% | +15.34% |
Average DrawdownAverage peak-to-trough decline | -5.91% | -14.53% | +8.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.04% | 8.41% | -2.37% |
Volatility
BIVRX vs. UPRO - Volatility Comparison
The current volatility for Invenomic Fund (BIVRX) is 7.79%, while ProShares UltraPro S&P 500 (UPRO) has a volatility of 16.04%. This indicates that BIVRX experiences smaller price fluctuations and is considered to be less risky than UPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIVRX | UPRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.79% | 16.04% | -8.25% |
Volatility (6M)Calculated over the trailing 6-month period | 16.78% | 28.48% | -11.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.81% | 54.36% | -33.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.96% | 50.34% | -33.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.11% | 53.69% | -36.58% |